Clinical Trial Update: Initial Safety Assessment of SNS-595 for the Treatment of Solid Tumors. [Phase 1]

View source ↗

Summary

This Phase 1 report presents the initial safety assessment results for SNS-595 in solid tumors.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neoplasms

Drugs mentioned

• SNS-595

Snippet

Sponsor: Sunesis Pharmaceuticals | Conditions: Neoplasms | Phase 1 | Status: COMPLETED